Boston Scientific Accumulated Goodwill Impairment Losses remained flat by 0.0% to $9.90B in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $9.90B to $9.90B.
accumulated_goodwill_impairment| Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | $9.90B | $9.90B | $9.90B | $9.90B | $9.90B | $9.90B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% |